ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
To join the GSK class action, go to https://rosenlegal.com/submit-form/?case_id=34609 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class ...
Investor Alert: Robbins LLP Informs Stockholders Of The GSK PLC Class Action
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Energize Supports Four Global Healthcare Companies Collaborating on a Multi-buyer PPA for a Long-term Supply of Renewable Electricity
Schneider Electric, today announced continued progress toward decarbonization for the pharmaceutical and healthcare sectors.
GSK is emerging from its long convalescence
Yet GSK is clearly healing from its multiple comorbidities — the worst of which was the (now largely resolved) legal overhang related to heartburn medicine Zantac. Chief executive Emma Walmsley also ...
GSK lifts long-term sales outlook on strong Specialty Medicines growth
GSK’s global performance showed strength across key markets. Sales in the United States reached £16.4 billion, up 6% at ...
GSK PLC Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors Of The Class Action Lawsuit Against GSK
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate ...
FTSE 100 Roughly Flat; GSK Rises Over 5%
UK stocks are moving in a tight band Wednesday morning with investors largely focusing on earnings updates, and digesting the data on ...
The Pharma Letter5d
Dynamic pipeline powers GSK through vaccine worries
GSK (LSE: GSK) has reported a 7% increase in full-year revenue for 2024, reaching £31.4 billion ($39.3 billion), slightly ...
London midday: Stocks slightly higher; GSK jumps on guidance upgrade
(Sharecast News) - London stocks were still a touch higher by midday on Wednesday as investors continued to mull the impact of Trump's trade war, with GSK surging after it lifted its long-term sales ...
LONDON BRIEFING: GSK hails pipeline as ups 2031 sales target
In early UK corporate news, GSK announced a buyback and upped its 2031 sales target. Here is what you need to know at the London market open: FTSE 100: called down 0.3% at 8,542.57 Hang Seng: down 1.0 ...
European markets open mixed ahead of more earnings reports; GSK up 6%
European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.